跳至主要内容
临床试验/NCT02270333
NCT02270333已完成不适用

Effects of Inspiratory Muscle Training in Patients With Sarcoidosis

Gazi University0 个研究点目标入组 30 人开始时间: 2012年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30
主要终点
Maximum inspiratory and expiratory muscle strength (MIP, MEP)

研究概览

简要总结

Respiratory muscle weakness results with decreased exercise capacity, worse fatigue, dyspnea and quality of life in patients with sarcoidosis. However, no study investigated the effects of inspiratory muscle training (IMT), therefore effects of IMT on outcomes in patients with sarcoidosis were investigated.

详细描述

Patients were diagnosed with sarcoidosis according to the criteria of the latest American Thoracic Society (ATS)/European Respiratory Society (ERS)/World Association of Sarcoidosis and Other Granulomatous (WASOG) Disorders statement on sarcoidosis. Primary outcome measurement was respiratory muscle strength, secondary outcomes were, exercise capacity quality of life, fatigue and depression.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinically stable
  • Under standard medication
  • Stage I and IV
  • No change in medications over three months

排除标准

  • Cognitive disorders
  • Current corticosteroid use
  • Having co-morbidity to prevent performing IMT
  • Acute infection
  • Orthopedic and neurological problems

结局指标

主要结局

Maximum inspiratory and expiratory muscle strength (MIP, MEP)

时间窗: 6 weeks

Mouth pressure device

次要结局

  • Exercise Capacity(6 weeks)
  • Pulmonary function and diffusing capacity(6 weeks)
  • Fatigue(6 weeks)
  • Dyspnea(6 weeks)
  • Maximal Exercise Capacity(6 weeks)
  • Peripheral muscle strength(6 weeks)
  • Quality of life(6 weeks)
  • Depression(6 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Meral Boşnak Güçlü

Assoc. Prof.

Gazi University

相似试验